humanitarian
Archived signal Translated · Українська · 2–5m lag
Звіт про людські ліки (EPAR): Duaklir Genuair, aclidium bromidi,formoterol, Date of Permissionation: 19/ 11/2014, resize: 18, status: Asisted
Звіт з питань людських ліків (EPAR) (EDAR): Azantive, ablibercecopet, Date of Pentification: 13/01/2025, revision: 6, Status: Authorized
Reported by EMA What Is New
Read the complete report at EMA What Is New ↗
Verification notice
IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.
8 reports · 2 sources
EMA What Is NewЗвіт про людські ліки (EPAR): Duaklir Genuair, aclidium bromidi,formoterol, Date of Permissionation: 19/ 11/2014, resize: 18, status: AsistedEMA What Is NewЗвіт про людські ліки (EPAR): Duaklir Genuair, aclidium bromidi,formoterol, Date of Permissionation: 19/ 11/2014, resize: 18, status: AsistedEMA What Is NewHuman medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 11, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Byfavo, remimazolam, Date of authorisation: 26/03/2021, Revision: 11, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Taxotere, docetaxel, Date of authorisation: 27/11/1995, Revision: 53, Status: AuthorisedEMA What Is NewHuman medicines European public assessment report (EPAR): Taxotere, docetaxel, Date of authorisation: 27/11/1995, Revision: 53, Status: AuthorisedEMA What Is NewЗвіт про лікування людських ліків (EPAR): Kigevvi, doxecitin,doxribitine, Date of Pentification: 26/03/2026, resization: 1, Стан: авторствоEMA What Is NewЗвіт про лікування людських ліків (EPAR): Kigevvi, doxecitin,doxribitine, Date of Pentification: 26/03/2026, resization: 1, Стан: авторство2 recorded states
Signal first indexedP2 · 99% quality · 2 sources
Headline updatedP2 · 99% quality · 2 sources